HighTower Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-300
Closed -$15 3848
2024
Q4
$15 Hold
300
﹤0.01% 3793
2024
Q3
$1.44K Buy
+300
New +$16.9K ﹤0.01% 3650
2022
Q2
Sell
-6
Closed -$2K 3328
2022
Q1
$2K Buy
+6
New +$439 ﹤0.01% 3336
2021
Q1
Sell
-3
Closed -$4K 3117
2020
Q4
$4K Buy
+3
New +$363 ﹤0.01% 2542
2020
Q2
Sell
-700
Closed -$2K 2462
2020
Q1
$2K Buy
+700
New +$56.8K ﹤0.01% 2173
2019
Q3
Sell
-100
Closed -$1K 2447
2019
Q2
$1K Hold
100
﹤0.01% 2364
2019
Q1
$1K Buy
+100
New +$8.51K ﹤0.01% 2271
2018
Q1
Sell
-200
Closed -$1K 2234
2017
Q4
$1K Buy
+200
New +$10.7K ﹤0.01% 2251
2017
Q3
Sell
-100
Closed -$2K 2265
2017
Q2
$2K Sell
100
-1,500
-94% -$46.3K ﹤0.01% 2176
2017
Q1
$6K Buy
1,600
+100
+7% +$1.98K ﹤0.01% 2031
2016
Q4
$1K Buy
+1,500
New +$24.2K ﹤0.01% 1913
2014
Q2
Sell
-10,000
Closed -$15K 1630
2014
Q1
$15K Sell
10,000
-25,000
-71% -$338K ﹤0.01% 1508
2013
Q4
$72K Buy
+35,000
New +$402K ﹤0.01% 1396

Other funds holding EXAS

HighTower Advisors's EXAS Position: Q1 2026 in Review

HighTower Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,227,761 shares — an estimated $125M sold.

HighTower Advisors first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $125M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • HighTower Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • HighTower Advisors sold 1,227,761 Exact Sciences shares in Q1 2026, an estimated $125M.
  • HighTower Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • HighTower Advisors's Exact Sciences position peaked at $125M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.